MYCIO Wealth Partners’s Emergent Biosolutions EBS Stock Holding History

MYCIO Wealth Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500	Closed	-$16K	–	335
2016 Q3	$16K	Hold	500	–	–	﹤0.01%	500
2016 Q2	$14K	Hold	500	–	–	﹤0.01%	514
2016 Q1	$18K	Hold	500	–	–	﹤0.01%	448
2015 Q4	$20K	Hold	500	–	–	﹤0.01%	426
2015 Q3	$14K	Hold	500	–	–	﹤0.01%	513
2015 Q2	$16K	Hold	500	–	–	﹤0.01%	463
2015 Q1	$14K	Hold	500	–	–	﹤0.01%	443
2014 Q4	$14K	Hold	500	–	–	﹤0.01%	429
2014 Q3	$11K	Hold	500	–	–	﹤0.01%	436
2014 Q2	$11K	Hold	500	–	–	﹤0.01%	457
2014 Q1	$13K	Hold	500	–	–	﹤0.01%	439
2013 Q4	$11K	Hold	500	–	–	﹤0.01%	437
2013 Q3	$10K	Hold	500	–	–	﹤0.01%	407
2013 Q2	$7K	Buy	+500	New	+$7.24K	﹤0.01%	447

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MYCIO Wealth Partners's EBS Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Emergent Biosolutions (EBS) in Q4 2016, closing a stake of 500 shares — an estimated $16K sold.

MYCIO Wealth Partners first reported a position in EBS in Q2 2013 and held it in 14 quarters. The position peaked at $20K in Q4 2015. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

MYCIO Wealth Partners reported no remaining Emergent Biosolutions position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 500 Emergent Biosolutions shares in Q4 2016, an estimated $16K.
MYCIO Wealth Partners first reported a position in Emergent Biosolutions in Q2 2013 and held it in 14 quarters.
MYCIO Wealth Partners's Emergent Biosolutions position peaked at $20K in Q4 2015.
208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.